Back to all Companies

Dyania Health, Inc

Visit Website
Healthcare & Life SciencesPharmaceuticals, Diagnostics & Life Sciences
Year Founded
Year Selected
New York, US / Athens, Greece
Team Size


Proprietary Physician-Trained A.I. Prioritizing Patients’ Best Health Outcomes through Clinical Research

Founded in 2019, Dyania Health is a venture-backed company which has developed Synapsis AI, a proprietary and regulatory compliant technology solution leveraging natural language processing and data analytics to automate and streamline manual chart reviews of electronic medical records (EMRs). Synapsis AI has the unique ability to pinpoint combinations of dynamically changing clinical characteristics in EMRs over time, making it an effective tool across multiple applications, from pre-screening patients for clinical studies to external control arms and market access studies. Led by an all-star team of former senior Amazon Alexa NLP scientists, Dyania Health's engineering team combines with a clinical advisory and in-house physician team to develop a rule-based clinical decision tool.

Through the power of NLP technology, complemented by clinician-driven logic for in-depth understanding of complex trial criteria, Dyania’s platform minimizes the need for manual chart reviews. Synapsis AI uses free text clinical notes commonly found in documents typed by medical professionals to extract the corresponding clinical meaning without including protected health information, such as name, geographical location, contact information amongst other identifying data. Dyania Health's Synapsis AI technology is a game-changer across the healthcare industry, offering an efficient, accurate, and cost-effective solution for pre-screening patients for clinical studies and building EMR data sets that can be leveraged to advance clinical research and understanding.


Dyania Health is disrupting and transforming the way companies and research organizations leverage unstructured data that can create immense clinical value. The Dyania Health team has a combined over 800 academic publications and 120 years of experience in clinical research, drug development, and clinical technologies with backgrounds across top-tier organizations including Morgan Stanley and Amazon.


investor logo
ScaleUp Program

Relevant Resources

See All

Endeavor ScaleUp 5th batch: 13 most promising high-growth companies that lead the way

Nov 10, 2022